What Is Treace Medical Concepts, Inc. (TMCI) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Treace Medical Concepts, Inc.'s intrinsic value is estimated at $3.62, presenting a divided outlook at the current price of $4.44. With an average implied return of -18.5% across a split 5–5 (bull–bear) consensus, the model spread of +135.2% underscores analytical uncertainty. Notably, Regime Cross sees the most upside at +41.1% (fair value: $6.26), while Dynamic NAV is the most conservative at -94.1% ($0.26). The spread between these extremes — +135.2% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About TMCI?
11 of 13 models are currently active for TMCI. Of these, 5 models suggest upside while 6 models suggest overvaluation. The Bayesian DCF estimates TMCI's intrinsic value at $0.73, implying -83.5% downside from the current price. See which stocks rank higher →
How Does TMCI Rank in Surgical & Medical Instruments & Apparatus?
Among 117 Surgical & Medical Instruments & Apparatus stocks, TMCI ranks #50 by Quality of Company score. CirclFi's QOC score of 6.8/10 evaluates 32 fundamental signals. A score of 6.8 indicates above-average quality.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
Treace Medical Concepts, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is TMCI a Value Trap?
CirclFi's Value Trap algorithm assigns TMCI a score of 28/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Treace Medical Concepts, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Treace Medical Concepts, Inc.'s fundamental quality profile registers 6.8/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +135.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every TMCI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across TMCI's 11 active models, average confidence is 28%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad